Cronos Group Inc CRON
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if CRON is a good fit for your portfolio.
News
-
Cronos's stock leaps as strong cannabis-flower sales lead to record revenue
-
Cannabis stocks rally after report that DEA will reclassify drug as less dangerous
-
Aurora leads Canadian cannabis stocks higher after pot trade group beefs up ranks with industry exec
-
Toronto Stocks Advance; Canadian Imperial Bank of Commerce Up on 1Q Profit, Revenue Rise
-
Curaleaf, Truelive, Verano could benefit from marijuana reclassification
-
Green Thumb, Trulieve and other cannabis stocks up as much as 23% as details emerge on HHS recommendation to lower drug classification
-
Canadian cannabis company Cronos Group sells Peace Naturals campus for about $17M
-
Organigram's stock soars as British American Tobacco invests $91.3 million
Trading Information
- Previous Close Price
- $2.85
- Day Range
- $2.76–2.93
- 52-Week Range
- $1.64–2.99
- Bid/Ask
- $2.77 / $2.78
- Market Cap
- $1.06 Bil
- Volume/Avg
- 2.8 Mil / 3.3 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 12.45
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Cronos Group, headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S. the company has an option to acquire 10.5% of U.S. multistate operator PharmaCann upon easing of federal prohibition.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 356
- Website
- https://www.thecronosgroup.com
Competitors
Valuation
|
Metric
|
CRON
|
TLRY
|
ACB
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | — |
Price/Book Value | 0.99 | 0.46 | 0.79 |
Price/Sales | 12.45 | 1.90 | 1.14 |
Price/Cash Flow | — | — | — |
Price/Earnings
CRON
TLRY
ACB
Financial Strength
|
Metric
|
CRON
|
TLRY
|
ACB
|
|---|---|---|---|
Quick Ratio | 21.68 | 0.96 | 1.79 |
Current Ratio | 22.54 | 1.92 | 3.79 |
Interest Coverage | — | −4.39 | — |
Quick Ratio
CRON
TLRY
ACB
Profitability
|
Metric
|
CRON
|
TLRY
|
ACB
|
|---|---|---|---|
Return on Assets (Normalized) | −0.53% | −1.42% | — |
Return on Equity (Normalized) | −0.55% | −1.82% | — |
Return on Invested Capital (Normalized) | −4.90% | −0.92% | — |
Return on Assets
CRON
TLRY
ACB
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Ddhlrqpczf | Sfn | $77.1 Bil | |
MKKGY
| Merck KGaA ADR | Qzqfftdp | Gknlq | $72.9 Bil | |
HLN
| Haleon PLC ADR | Wcmwvkgk | Wrzl | $37.5 Bil | |
VTRS
| Viatris Inc | Lydpnlrx | Lwjnx | $13.3 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Plscfcyp | Qwmlr | $11.7 Bil | |
CTLT
| Catalent Inc | Yqdtvkwxk | Ffgzvs | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Qwcsfkw | Kmrl | $4.2 Bil | |
CURLF
| Curaleaf Holdings Inc | Cshynwtl | Cqzrs | $4.0 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Jvdydrwf | Dsfmdzw | $3.5 Bil | |
GTBIF
| Green Thumb Industries Inc | Mdwdmsjld | Fwt | $3.0 Bil |